Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Phase 1 Completed 60 enrolled Beijing Chaoyang District Centre for Disease Control and Prevention

Non-randomizedSingle-groupOpen-labelPrevention

Summary

This phase I clinical study evaluates the safety of ACYW135 meningococcal polysaccharide vaccine in population aged 2-6, 7-17, 18-50 years old by the method of both passive and active surveillance.

Timeline

Start: 2016-03
Primary completion: 2016-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ACYW135 Meningococcal Polysaccharide Vaccine	Vaccine	—	—

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Summary

Timeline

Drugs

Indications